PCN68 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC)- THE PRIVATE HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL
Abstract
Authors
N Muszbeck H Vioix U Munir A Schiola A Valderrama V Teich